此剂量肝素的应用可避免出血倾向等不良反应的发生；
Heparin of the above dose can avoid the hemorrhage reaction.
目的：采用微剂量肝素治疗危重患儿dic，评价其疗效。
Objective: Use mini dose heparin to treat DIC in critically ill children and evaluate its curative effect.
此外转流期预防性应用小剂量肝素，并不影响转流后凝血功能。
The small dose of heparin administration did not interfere with the blood coagulation.
本文报告20例应用小剂量肝素治疗冠心病心绞痛的临床效果。
This paper reported the effect of Heparin in treating 20 cases of angina pectoris.
目的：了解小剂量肝素钙治疗不稳定性心绞痛(uap)的作用。
AIM: to study the effect of small dose of heparin calcium in treatment of unstable angina pectoris (UAP).
目的探讨小剂量肝素对肾综合征出血热（HFRS）的临床意义。
Objective To discuss the clinical significance of heparin sodium for hemorrhagic fever with renal syndrome(HFRS).
目的：研究小剂量肝素辅以综合治疗产科弥漫性血管内凝血的疗效。
Objective: To study the efficacy of small-dose heparin and general treatment in patients with acute DIC complicated by obstetrics.
目的：探讨大剂量肝素超声雾化吸入辅助治疗哮喘急性发作的疗效。
Objective:In order to determine the therapeutic effects of large doses of heparin inhaled in the aerosol formation for the treatment of acute episode of severe asthma.
观察组患者在此基础上加用小剂量肝素，对照组加用等剂量生理盐水。
Observation group patients were treated with low dose of heparin on the basis of the above treatment.
采用侧切口放血结合中小剂量肝素化治疗及髓腔通血方法建立血液循环。
The blood circulation of the fingers was rebuilt by releasing blood from lateral incisions, administration heparin with minimal to medium dose and blood filling of the medullary cavity.
医疗管理与小剂量肝素，潘生丁，阿司匹林导致改善头部肿胀和乳糜胸。
Medical management with low-dose heparin, dipyridamole, and aspirin resulted in improvements of head swelling and chylothorax.
结论：小剂量肝素钠治疗过敏性紫癜尤其顽固性腹型紫癜，无明显不良反应，疗效可靠。
Conclusions:Lowdose heparin in treatment of henochschonlein purpura, particularly of intractable abdominal purpura is effective and reliable without side effects.
目的观察小剂量肝素对危重新生儿全身炎症反应综合征（SIRS）的治疗效果及预后的影响。
Objective To observe the intervention of systemic inflammatory response syndrome (SIRS) at early stage in newborn infants with low-dose heparin.
目的采用大鼠盲肠结扎穿孔术(CLP)复制大鼠脓毒症模型，探讨应用小剂量肝素对脓毒症早期的干预作用。
Objective To explore the early intervention role of the application of low-dose heparin on sepsis through rats in cecal ligation and puncture (CLP) model.
结论：低剂量缓给UK加肝素维持的溶栓方案适用于不稳定型心绞痛的治疗。
Conclusion: the thrombolytic therapy program of low dosage and slow medication of UK combined with heparin fit for treatment of UA.
目的探讨小剂量尿激酶与低分子肝素钙治疗急性脑梗死的疗效。
Objective To discuss the curative effect of the small dosage urokinase and the low molecular heparin calcium on cerebral infarction.
目的：观察小剂量低分子肝素钙治疗糖尿病肾病的疗效。
Objective: To observe the curative effect of small dose low molecular heparin calcic in the treatment of diabetic nephropathy.
结论大剂量纳洛酮联合低分子肝素治疗急性脑梗死安全有效。
ConclusionsThis an effective and safe therapy which treats the acute cerebral infarction by large dose of naloxone combined with low-molecular-weight heparin calcium.
结论联合应用替罗非班可降低抗凝肝素剂量，显著抑制血小板聚集，并呈降低降低血小板数的趋势。
Conclusions Addition to the conventional therapies with anti-platelets and anti-coagulation, tirofiban can reduce the dose of heparin, inhibit platelet aggregation and decrease the platelets number.
目前正在使用的经fDA批准的肝素标签(包括其中的推荐剂量)并未做修改。
The current FDA-approved labeling for heparin remains unchanged, including the recommended doses.
小剂量低分子肝素、胃肠外营养及生长抑素的联合应用具有较佳的疗效。
Small dosage of low molecular weight heparin, parenteral nutritional support and somatostatin therapy have the therapeutical effects to some extent.
目的观察不同剂量低分子肝素(LMWH)对急性脑梗死(aci)患者的疗效。
Objective To observe the curative effect of different dosages of low molecular weight heparin (LMWH) in patients with acute cerebral infarction (ACI).
目的：评价低分子肝素钙联合大剂量纳洛酮治疗早期急性脑梗死的临床疗效和安全性。
AIM: To evaluate the therapeutic effect and safety of low molecular weight heparin calcium combined with naloxone on acute cerebral infraction in early stage.
然后，分别进行“配对差异”试验和“剂量效应”试验以及肝素干扰LAP测定的浓度范围的评价。
The "paired difference" experiment and "dose-response" experiment were determined. LAP concentration range of heparin interference was evaluated.
包括低分子肝素（LMWHs），合成的戊多糖，调整剂量的华法林，阿斯匹林以及物理预防措施。
Included in the options are low molecular weight heparins (LMWHs), synthetic pentasaccharides, adjusted-dose warfarin, aspirin, and mechanical prophylaxis.
目的：探讨低剂量鱼精蛋白拮抗肝素围体外循环(cpb)期血浆肝素浓度变化的规律及其与术后凝血功能损害的关系。
Objective To investigate the change of plasma heparin concentration and relationship with blood coagulation dysfunction during and after cardiopulmonary bypass (CPB).
结论：与标准剂量的普通肝素相比，低剂量普通肝素不能减少主要的PCI相关的出血和血管穿刺点并发症的发生。
Conclusion Low-dose compared with standard-dose unfractionated heparin did not reduce major peri-PCI bleeding and vascular access-site complications.
目的探讨替罗非班对急性冠状动脉综合征患者对抗凝肝素剂量及血小板计数和功能的影响。
Objectives To explore the effects of tirofiban on dose of heparin and platelet aggregation in the patients with acute coronary artery syndrome.
目的：比较在用磺达肝素治疗过的非ST段抬高性急性冠脉综合症的高危患者行PCI时使用的两种不同剂量普通肝素的安全性。
Objective To compare the safety of 2 unfractionated heparin regimens during PCI in high-risk patients with non–ST-segment elevation acute coronary syndromes initially treated with fondaparinux.
目的：比较在用磺达肝素治疗过的非ST段抬高性急性冠脉综合症的高危患者行PCI时使用的两种不同剂量普通肝素的安全性。
Objective To compare the safety of 2 unfractionated heparin regimens during PCI in high-risk patients with non–ST-segment elevation acute coronary syndromes initially treated with fondaparinux.
应用推荐